ANIXA BIOSCIENCES, INC. Payments to Acquire Short-term Investments
ANIXA BIOSCIENCES, INC. (ANIX) reported Payments to Acquire Short-term Investments of $34.42 million for the 9-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-09-09
- ANIXA BIOSCIENCES, INC. payments to acquire short-term investments for the quarter ending 2026-07-31 was $9.78M, a 16.95% decline year-over-year.
- ANIXA BIOSCIENCES, INC. payments to acquire short-term investments for the quarter ending 2026-04-30 was $12.11M, a 1.49% increase year-over-year.
- ANIXA BIOSCIENCES, INC. payments to acquire short-term investments for the quarter ending 2026-01-31 was $12.53M, a 3.58% decline year-over-year.
- ANIXA BIOSCIENCES, INC. payments to acquire short-term investments for the quarter ending 2025-10-31 was $7.66M, a 53.47% decline year-over-year.
- ANIXA BIOSCIENCES, INC. payments to acquire short-term investments for fiscal 2025 was $44.36M, a 30.44% decline from fiscal 2024.
- ANIXA BIOSCIENCES, INC. payments to acquire short-term investments for fiscal 2024 was $63.77M, a 43.59% increase from fiscal 2023.
- ANIXA BIOSCIENCES, INC. payments to acquire short-term investments for fiscal 2023 was $44.41M, a 97.51% increase from fiscal 2022.
- ANIXA BIOSCIENCES, INC. payments to acquire short-term investments for fiscal 2022 was $22.49M, a 36.30% increase from fiscal 2021.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 6 month as first filed | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 9 month as first filed | Payments to Acquire Short-term Investments 12 month | Payments to Acquire Short-term Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-07-31 | $9.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-09-09 | $21.89M derived: sum of 2 quarters · filed 2026-09-09 | $34.42M 10-Q · filed 2026-09-09 | $42.08M derived: sum of 4 quarters · filed 2026-09-09 | |||
| 2026-04-30 | $12.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-06-10 | $24.64M 10-Q · filed 2026-06-10 | $32.30M derived: sum of 3 quarters · filed 2026-06-10 | $44.07M derived: sum of 4 quarters · filed 2026-09-09 | |||
| 2026-01-31 | $12.53M 10-Q · filed 2026-03-09 | $20.19M derived: sum of 2 quarters · filed 2026-03-09 | $31.96M derived: sum of 3 quarters · filed 2026-09-09 | $43.90M derived: sum of 4 quarters · filed 2026-09-09 | |||
| 2025-10-31 | $7.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $19.43M derived: sum of 2 quarters · filed 2026-09-09 | $31.36M derived: sum of 3 quarters · filed 2026-09-09 | $44.36M 10-K · filed 2026-01-12 | |||
| 2025-07-31 | $11.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-09-09 | $23.70M derived: sum of 2 quarters · filed 2026-09-09 | $36.70M 10-Q · filed 2026-09-09 | $53.16M derived: sum of 4 quarters · filed 2026-09-09 | |||
| 2025-04-30 | $11.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-06-10 | $24.93M 10-Q · filed 2026-06-10 | $41.39M derived: sum of 3 quarters · filed 2026-06-10 | $53.96M derived: sum of 4 quarters · filed 2026-06-10 | |||
| 2025-01-31 | $13.00M 10-Q · filed 2026-03-09 | $29.46M derived: sum of 2 quarters · filed 2026-03-09 | $42.03M derived: sum of 3 quarters · filed 2026-03-09 | $56.75M derived: sum of 4 quarters · filed 2026-03-09 | |||
| 2024-10-31 | $16.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $29.03M derived: sum of 2 quarters · filed 2026-01-12 | $43.75M derived: sum of 3 quarters · filed 2026-01-12 | $63.77M 10-K · filed 2026-01-12 | |||
| 2024-07-31 | $12.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-09-10 | $27.29M derived: sum of 2 quarters · filed 2025-09-10 | $47.31M 10-Q · filed 2025-09-10 | $64.22M derived: sum of 4 quarters · filed 2025-09-10 | |||
| 2024-04-30 | $14.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-28 | $34.74M 10-Q · filed 2025-05-28 | $51.65M derived: sum of 3 quarters · filed 2025-05-28 | $61.74M derived: sum of 4 quarters · filed 2025-05-28 | |||
| 2024-01-31 | $20.02M 10-Q · filed 2025-03-11 | $36.93M derived: sum of 2 quarters · filed 2025-03-11 | $47.02M derived: sum of 3 quarters · filed 2025-03-11 | $56.60M derived: sum of 4 quarters · filed 2025-03-11 | |||
| 2023-10-31 | $16.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-10 | $27.00M derived: sum of 2 quarters · filed 2025-01-10 | $36.58M derived: sum of 3 quarters · filed 2025-01-10 | $44.41M 10-K · filed 2025-01-10 | |||
| 2023-07-31 | $10.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-09-06 | $19.67M derived: sum of 2 quarters · filed 2024-09-06 | $27.50M 10-Q · filed 2024-09-06 | $38.83M derived: sum of 4 quarters · filed 2024-09-06 | |||
| 2023-04-30 | $9.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-06-04 | $17.41M 10-Q · filed 2024-06-04 | $28.73M derived: sum of 3 quarters · filed 2024-06-04 | $35.64M derived: sum of 4 quarters · filed 2024-06-04 | |||
| 2023-01-31 | $7.83M 10-Q · filed 2024-03-12 | $19.16M derived: sum of 2 quarters · filed 2024-03-12 | $26.07M derived: sum of 3 quarters · filed 2024-03-12 | $26.82M derived: sum of 4 quarters · filed 2024-03-12 | |||
| 2022-10-31 | $11.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-16 | $18.24M derived: sum of 2 quarters · filed 2024-01-16 | $18.99M derived: sum of 3 quarters · filed 2024-01-16 | $22.49M 10-K · filed 2024-01-16 | |||
| 2022-07-31 | $6.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-09-06 | $7.66M derived: sum of 2 quarters · filed 2023-09-06 | $11.16M 10-Q · filed 2023-09-06 | $17.26M derived: sum of 4 quarters · filed 2023-09-06 | |||
| 2022-04-30 | $750.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-06-14 | $4.25M 10-Q · filed 2023-06-14 | $10.35M derived: sum of 3 quarters · filed 2023-06-14 | $10.35M derived: sum of 4 quarters · filed 2023-06-14 | |||
| 2022-01-31 | $3.50M 10-Q · filed 2023-03-17 | $9.60M derived: sum of 2 quarters · filed 2023-03-17 | $9.60M derived: sum of 3 quarters · filed 2023-03-17 | $19.00M derived: sum of 4 quarters · filed 2023-03-17 | |||
| 2021-10-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-04 | $6.10M derived: sum of 2 quarters · filed 2023-01-04 | $15.50M derived: sum of 3 quarters · filed 2023-01-04 | $16.50M 10-K · filed 2023-01-04 | $16.50M 10-K · filed 2022-01-04 | ||
| 2021-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-09-09 | $9.40M derived: sum of 2 quarters · filed 2022-09-09 | $10.40M 10-Q · filed 2022-09-09 | $10.40M 10-Q · filed 2021-09-01 | $9.90M derived: sum of 4 quarters · filed 2022-09-09 | ||
| 2021-04-30 | $9.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-06-10 | $10.40M 10-Q · filed 2022-06-10 | $10.40M 10-Q · filed 2021-06-10 | $9.90M derived: sum of 3 quarters · filed 2022-06-10 | $12.79M derived: sum of 4 quarters · filed 2022-06-10 | ||
| 2021-01-31 | $1.00M 10-Q · filed 2022-03-11 | $500.00K derived: sum of 2 quarters · filed 2022-03-11 | $3.39M derived: sum of 3 quarters · filed 2022-03-11 | $4.14M derived: sum of 4 quarters · filed 2022-03-11 | |||
| 2020-10-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-01-04 | $2.39M derived: sum of 2 quarters · filed 2022-01-04 | $3.14M derived: sum of 3 quarters · filed 2022-01-04 | $5.01M 10-K · filed 2022-01-04 | |||
| 2020-07-31 | $2.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-09-01 | $3.64M derived: sum of 2 quarters · filed 2021-09-01 | $5.51M 10-Q · filed 2021-09-01 | $7.01M derived: sum of 4 quarters · filed 2021-09-01 | |||
| 2020-04-30 | $750.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-06-10 | $2.62M 10-Q · filed 2021-06-10 | $4.12M derived: sum of 3 quarters · filed 2021-06-10 | $5.47M derived: sum of 4 quarters · filed 2021-06-10 | |||
| 2020-01-31 | $1.87M 10-Q · filed 2021-03-11 | $3.37M derived: sum of 2 quarters · filed 2021-03-11 | $4.72M derived: sum of 3 quarters · filed 2021-03-11 | ||||
| 2019-10-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-07 | $2.85M derived: sum of 2 quarters · filed 2021-01-07 | $3.85M 10-K · filed 2021-01-07 | ||||
| 2019-07-31 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-09-08 | $2.35M 10-Q · filed 2020-09-08 | |||||
| 2019-04-30 | $1.00M 10-Q · filed 2020-06-09 | ||||||
| 2018-10-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09 | $3.00M derived: sum of 2 quarters · filed 2020-01-09 | $3.00M derived: sum of 3 quarters · filed 2020-01-09 | $4.25M 10-K · filed 2020-01-09 | |||
| 2018-07-31 | $2.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-09-06 | $2.75M derived: sum of 2 quarters · filed 2019-09-06 | $4.00M 10-Q · filed 2019-09-06 | $5.25M derived: sum of 4 quarters · filed 2019-09-06 | |||
| 2018-04-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-06-12 | $1.25M 10-Q · filed 2019-06-12 | $2.50M derived: sum of 3 quarters · filed 2019-06-12 | $4.50M derived: sum of 4 quarters · filed 2019-06-12 | |||
| 2018-01-31 | $1.25M 10-Q · filed 2019-03-13 | $2.50M derived: sum of 2 quarters · filed 2019-03-13 | $4.50M derived: sum of 3 quarters · filed 2019-03-13 | ||||
| 2017-10-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-11 | $3.25M derived: sum of 2 quarters · filed 2019-01-11 | $5.50M 10-K · filed 2019-01-11 | ||||
| 2017-07-31 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-09-07 | $4.25M 10-Q · filed 2018-09-07 | |||||
| 2017-04-30 | $2.25M 10-Q · filed 2018-06-11 | ||||||
| 2016-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-09 | $350.00K derived: sum of 2 quarters · filed 2018-01-09 | $1.65M derived: sum of 3 quarters · filed 2018-01-09 | $1.90M 10-K · filed 2018-01-09 | |||
| 2016-07-31 | $350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | $1.65M derived: sum of 2 quarters · filed 2017-09-08 | $1.90M 10-Q · filed 2017-09-08 | $2.25M derived: sum of 4 quarters · filed 2017-09-08 | |||
| 2016-04-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-26 | $1.55M 10-Q · filed 2017-05-26 | $1.90M derived: sum of 3 quarters · filed 2017-05-26 | $2.05M derived: sum of 4 quarters · filed 2017-05-26 | |||
| 2016-01-31 | $250.00K 10-Q · filed 2017-03-16 | $600.00K derived: sum of 2 quarters · filed 2017-03-16 | $750.00K derived: sum of 3 quarters · filed 2017-03-16 | $2.50M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-10-31 | $350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08 | $500.00K derived: sum of 2 quarters · filed 2016-12-08 | $2.25M derived: sum of 3 quarters · filed 2016-12-08 | $2.90M 10-K · filed 2016-12-08 | |||
| 2015-07-31 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-19 | $1.90M derived: sum of 2 quarters · filed 2016-08-19 | $2.55M 10-Q · filed 2016-08-19 | $4.05M derived: sum of 4 quarters · filed 2016-08-19 | |||
| 2015-04-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-20 | $2.40M 10-Q · filed 2016-05-20 | $3.90M derived: sum of 3 quarters · filed 2016-05-20 | $4.90M derived: sum of 4 quarters · filed 2016-05-20 | |||
| 2015-01-31 | $650.00K 10-Q · filed 2016-02-19 | $2.15M derived: sum of 2 quarters · filed 2016-02-19 | $3.15M derived: sum of 3 quarters · filed 2016-02-19 | $3.15M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-10-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $2.50M derived: sum of 2 quarters · filed 2015-12-23 | $2.50M derived: sum of 3 quarters · filed 2015-12-23 | $5.20M 10-K · filed 2015-12-23 | |||
| 2014-07-31 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-18 | $1.00M derived: sum of 2 quarters · filed 2015-08-18 | $3.70M 10-Q · filed 2015-08-18 | ||||
| 2014-04-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-22 | $2.70M 10-Q · filed 2015-05-22 | |||||
| 2014-01-31 | $2.70M 10-Q · filed 2015-03-09 | ||||||
| 2013-10-31 | $250.00K 10-K · filed 2015-01-29 | ||||||
| 2012-10-31 | $0.00 derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2014-01-17 | $200.00K derived: sum of 2 quarters · filed 2014-01-17 | $950.00K derived: sum of 3 quarters · filed 2014-01-17 | $1.20M 10-K/A · filed 2014-01-17 | |||
| 2012-07-31 | $200.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-09-20 | $950.00K derived: sum of 2 quarters · filed 2013-09-20 | $1.20M 10-Q/A · filed 2013-09-20 | $1.40M derived: sum of 4 quarters · filed 2013-09-20 | |||
| 2012-04-30 | $750.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-06-19 | $1.00M 10-Q/A · filed 2013-06-19 | $1.20M derived: sum of 3 quarters · filed 2013-06-19 | $3.40M derived: sum of 4 quarters · filed 2013-06-19 | |||
| 2012-01-31 | $250.00K 10-Q/A · filed 2013-03-25 | $450.00K derived: sum of 2 quarters · filed 2013-03-25 | $2.65M derived: sum of 3 quarters · filed 2013-03-25 | ||||
| 2011-10-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | $2.40M derived: sum of 2 quarters · filed 2013-01-29 | $3.95M 10-K · filed 2013-01-29 | ||||
| 2011-07-31 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-14 | $3.75M 10-Q · filed 2012-09-14 | |||||
| 2011-04-30 | $1.55M 10-Q · filed 2012-06-14 | ||||||
| 2010-10-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-01-30 | $749.87K 10-K · filed 2012-01-30 | |||||
| 2010-07-31 | $749.87K 10-Q/A · filed 2011-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |